TLX

Telix Pharmaceuticals
TLX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$20
103% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
David Dai
0% 1-yr TLX win rate
23 Sep ‘25 2 months ago
Citigroup
Citigroup
Laura Sutcliffe
50% 1-yr TLX win rate
18 Sep ‘25 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Robert Burns
50% 1-yr TLX win rate
10 Sep ‘25 2 months ago